Skip to main content

Search

1 result(s) for '"Redox-responsive targeted gelatin nanoparticles for delivery of combination wt-p53 expressing plasmid DNA and gemcitabine in the treatment of pancreatic cancer."' within BMC

Page 1 of 1

Sort by: Relevance | Date

  1. Pancreatic adenocarcinoma is one of the most dreaded cancers with very low survival rate and poor prognosis to the existing frontline chemotherapeutic drugs. Gene therapy in combination with a cytotoxic agent ...

    Authors: Jing Xu, Amit Singh and Mansoor M Amiji
    Citation: BMC Cancer 2014 14:75